Photobiomodulation Therapy for Stroke

Farzad Salehpour, Saeed Sadigh-Eteghad, Javad Mahmoudi, Farzin Kamari, Paolo Cassano, Michael Richard Hamblin

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

This chapter delves into the potential of photobiomodulation (PBM) therapy for stroke, providing an overview of the condition, discussing relevant animal models, and examining the therapeutic approach in both animal studies and human clinical trials. Section 1 introduces stroke, a leading cause of death and disability worldwide. The chapter discusses acute and chronic stroke (1.1), stroke-induced aphasia (1.2), and various animal models of stroke (1.3) that are crucial for understanding the disorder’s underlying mechanisms and testing potential therapeutic interventions, such as PBM. Section 2 focuses on PBM therapy for stroke, with subsections discussing its application in animal models (2.1) and human studies (2.3). This section provides a comprehensive overview of the current state of research, highlighting the potential benefits of PBM therapy in promoting neuroprotection, reducing brain damage, and enhancing functional recovery.

Original languageEnglish
Title of host publicationSynthesis Lectures on Biomedical Engineering
PublisherSpringer Nature
Pages221-258
Number of pages38
DOIs
Publication statusPublished - 2023

Publication series

NameSynthesis Lectures on Biomedical Engineering
VolumePart F1286
ISSN (Print)1930-0328
ISSN (Electronic)1930-0336

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biochemistry
  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Photobiomodulation Therapy for Stroke'. Together they form a unique fingerprint.

Cite this